List of insiders holdings for Royalty Pharma plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | Legorreta Pablo G. CEO, Chairman of the Board | 2025-05-23 17:05:26 | 103,112,796 0 | 103,112,796 | Form 13D |
2 | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner | 2022-12-07 16:30:47 | 0 33,547,592 | 33,547,592 | Form 4 |
3 | Avara Management Ltd Giuliani Mario Germano 10% Owner | 2024-01-03 16:31:02 | 7,747 32,547,592 | 32,555,339 | Form 4 |
4 | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Nogra Group SICAF - SIF S.A. Severgnini Achille G. Director 10% Owner | 2025-05-02 18:19:00 | 29,926,170 0 | 29,926,170 | Form 13D |
5 | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner | 2022-09-22 16:30:37 | 0 21,426,170 | 21,426,170 | Form 4 |
6 | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Skyeline Management Ltd Avara Management Ltd Director 10% Owner | 2022-12-05 16:44:39 | 0 11,406,894 | 11,406,894 | Form 4 |
7 | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 2023-02-09 11:06:35 | 7,000,000 0 | 7,000,000 | Form 13G |
8 | FORD WILLIAM E Director | 2021-06-30 17:11:32 | 6,597 2,039,768 | 2,046,365 | Form 4 |
9 | Lloyd George W. EVP, Investments & CLO | 2025-05-20 16:51:00 | 0 1,944,471 | 1,944,471 | Form 4 |
10 | Coyne Terrance P. EVP & CFO | 2025-05-20 16:52:53 | 0 1,807,277 | 1,807,277 | Form 4 |
11 | Urist Marshall EVP, Research & Investments | 2025-05-20 16:54:04 | 0 1,356,528 | 1,356,528 | Form 4 |
12 | Reddoch James F. EVP & Chief Scientific Officer | 2022-09-30 16:23:50 | 0 1,324,700 | 1,324,700 | Form 4 |
13 | Hite Christopher EVP & Vice Chairman | 2025-05-20 16:54:54 | 0 1,238,789 | 1,238,789 | Form 4 |
14 | RIGGS RORY B Director | 2024-02-22 19:23:26 | 590,099 100,187 | 690,286 | Form 4 |
15 | Fernandez Henry A Director | 2025-05-14 17:08:45 | 64,260 58,200 | 122,460 | Form 4 |
16 | Norden Gregory Director | 2025-05-14 17:12:13 | 83,688 0 | 83,688 | Form 4 |
17 | DESOUZA ERROL B Director | 2025-05-14 17:07:36 | 81,352 0 | 81,352 | Form 4 |
18 | Bassler Bonnie L Director | 2025-05-14 17:04:55 | 70,054 0 | 70,054 | Form 4 |
19 | LOVE TED W Director | 2025-05-14 17:11:13 | 53,848 0 | 53,848 | Form 4 |
20 | Engelbert Catherine M. Director | 2025-05-15 17:41:32 | 51,128 0 | 51,128 | Form 4 |
21 | HODGSON DAVID C Director | 2025-05-14 17:09:55 | 33,328 0 | 33,328 | Form 4 |
22 | Coric Vlad Director | 2025-05-14 17:06:22 | 10,798 0 | 10,798 | Form 4 |
23 | Royalty Pharma plc Director | 2025-04-21 17:18:50 | 0 0 | 0 | Form 3 |